Fund Overview
The Covered Bridge Fund was created with the goal of reducing risk during equity market volatility and extending income opportunities for investors.
At A Glance
-
Minimum Investment
$100,000 -
Investment Style
Large Value -
Category
Options-based -
Share Class Inception Date
10/01/13 -
Total Fund Assets as of 9/30/23
$118 Mil -
3 Yr Return as of 9/30/23
11.86% -
5 Yr Return as of 6/30/23
4.51%
-
Minimum Investment
$2,500 -
Investment Style
Large Value -
Category
Options-based -
Share Class Inception Date
10/01/13 -
Total Fund Assets as of 9/30/23
$118 Mil -
3 Yr Return as of 9/30/23
11.63% -
5 Yr Return as of 6/30/23
4.25%
Annual Principal Value and Payout
As of 9/30/23
Ending Principal | Payout | Cumulative Payout | |
2014 | 102,200 | 11,234 | 11,234 |
2015 | 93,800 | 5,330 | 16,564 |
2016 | 99,000 | 7,242 | 23,806 |
2017 | 101,100 | 7,687 | 31,493 |
2018 | 87,500 | 10,104 | 41,597 |
2019 | 96,900 | 6,391 | 47,988 |
2020 | 90,300 | 4,248 | 52,236 |
2021 | 100,500 | 7,581 | 59,817 |
2022 | 92,900 | 8,071 | 67,888 |
YTD 2023 | 85,100 | 5,591 | 73,479 |
Simple Average of Annual Payout (2014-2022)= 7,543
Starting in 2018, the fund transitioned from distributing capital gains annually to distributing capital gains on a quarterly basis.
Top 10 Equity Holdings
as of 9/30/23
Net Asset % | |
Avery Dennison Corporation | 3.55% |
QUALCOMM Inc. | 3.36% |
AT&T Inc. | 3.29% |
Johnson & Johnson | 2.95% |
Chesapeake Energy Corporation | 2.90% |
Pfizer Inc. | 2.79% |
Intel Corporation | 2.69% |
Medtronic plc | 2.64% |
US Bancorp | 2.50% |
Bristol-Myers Squibb Company | 2.44% |
Investment Performance
as of 9/30/23
Fund Name | 3M | YTD Return |
1Y | 3Y | 5Y | Since Inception 10/1/13 |
TCBIX | -2.44% | -2.46% | 10.96% | 11.86% | 4.51% | 6.08% |
TCBAX | -2.39% | -2.63% | 10.74% | 11.63% | 4.25% | 5.82% |
TCBAX with Load | -7.55% | -7.76% | 4.89% | 9.63% | 3.13% | 5.25% |
BXM Index | -2.84% | 7.33% | 14.62% | 7.22% | 2.83% | 5.80% |
Russell 1000 Value Index | -3.17% | 1.79% | 14.44% | 11.05% | 6.23% | 8.37% |
S&P 500 INDEX | -3.27% | 13.07% | 21.62% | 10.15% | 9.92% | 11.83% |
Performance data quoted above is historical. Past performance does not guarantee future results and current performance may be lower or higher than the performance data quoted. The investment return and principal value of an investment will fluctuate, so that shares when redeemed may be worth more or less than their original cost. For performance information current to the most recent month-end, please call 855-525-2151
There is no assurance that the fund will achieve its investment objectives. The investment return and principal value of an investment will fluctuate so that investor’s shares, when redeemed, may be worth more or less than their original cost. The Fund’s investment adviser has contractually agreed to reduce its fees and/or absorb expenses of the Fund, at least until January 31, 2023, the Fund’s gross total annual operating expenses would be 1.73% for Class A and 1.48% for Class I. The net annual fund operating expenses are 1.69% and 1.44% of the Fund’s average daily net assets for its Class A and Class I shares, subject to possible recoupment from the Fund in future years. Please review the fund’s prospectus for more information regarding the fund’s fees and expenses.